"I am very annoyed": Pharma execs blast RFK Jr.'s attack on vaccines
  • Jan 16, 2026

"I am very annoyed": Pharma execs blast RFK Jr.'s attack on vaccines
Sanofi sees near-term weakness in US vaccines sales due to antivax rhetoric
  • Jan 16, 2026

Sanofi sees near-term weakness in US vaccines sales due to antivax rhetoric

  • Reuters
US FDA delays two drug reviews in new expedited review program after safety, efficacy concerns
  • Jan 16, 2026

US FDA delays two drug reviews in new expedited review program after safety, efficacy concerns

  • Reuters
Food companies are targeting users of weight-loss drugs with 'GLP-1 Friendly' labels
  • Jan 14, 2026

Food companies are targeting users of weight-loss drugs with 'GLP-1 Friendly' labels

  • Associated Press
FDA tells pharma companies to remove suicide warnings from popular weight-loss drugs
  • Jan 13, 2026

FDA tells pharma companies to remove suicide warnings from popular weight-loss drugs

  • Associated Press
Nvidia, Eli Lilly to spend $1 billion over five years on joint research lab
  • Jan 13, 2026

Nvidia, Eli Lilly to spend $1 billion over five years on joint research lab

  • Reuters
Thermo Fisher wins contracts as pharma shifts production to US, CEO says
  • Jan 13, 2026

Thermo Fisher wins contracts as pharma shifts production to US, CEO says

  • Reuters
  • Jan 13, 2026

New drug candidate reverses metabolic liver disease and fibrosis, pre-clinical data show

  • McMaster University
Price of semaglutide drugs may drop more than half in Canada
  • Jan 12, 2026

Price of semaglutide drugs may drop more than half in Canada

  • Toronto Star
Health Canada approves 1st GLP-1 daily pill
  • Jan 12, 2026

Health Canada approves 1st GLP-1 daily pill

  • Global News
New Alzheimer's treatment given for the first time in Canada
  • Jan 10, 2026

New Alzheimer's treatment given for the first time in Canada

  • CTV News
A Glimpse of Hope That Alzheimer's Can Be Reversed
  • Jan 09, 2026

A Glimpse of Hope That Alzheimer's Can Be Reversed

  • The Tyee
J&J strikes deal with US government to cut drug prices, gain tariff exemptions
  • Jan 09, 2026

J&J strikes deal with US government to cut drug prices, gain tariff exemptions

  • Reuters
MS drug dimethyl fumarate possibly linked to serious GI adverse events
  • Jan 09, 2026

MS drug dimethyl fumarate possibly linked to serious GI adverse events

  • Canadian Healthcare Network
Study says pounds return fast after stopping weight-loss drugs
  • Jan 08, 2026

Study says pounds return fast after stopping weight-loss drugs

  • CTV News
Trump administration cannot proceed with pilot drug rebate program, US court rules
  • Jan 08, 2026

Trump administration cannot proceed with pilot drug rebate program, US court rules

  • Reuters
Is Trump lowering drug prices? What to know for his Trump's second term
  • Jan 07, 2026

Is Trump lowering drug prices? What to know for his Trump's second term

  • Axios
Bayer sues Moderna, J&J and Pfizer/BioNTech over COVID vax tech
  • Jan 07, 2026

Bayer sues Moderna, J&J and Pfizer/BioNTech over COVID vax tech

  • Fierce Pharma
Pharmacare claims for Ozempic have soared in Manitoba in last 4 years: provincial data
  • Jan 07, 2026

Pharmacare claims for Ozempic have soared in Manitoba in last 4 years: provincial data

  • CBC News
Novo Nordisk's US public affairs head leaves company, memo shows
  • Jan 07, 2026

Novo Nordisk's US public affairs head leaves company, memo shows

  • Reuters
Novo Nordisk Canada considers competing with generics through renamed lower-price Ozempic
  • Jan 07, 2026

Novo Nordisk Canada considers competing with generics through renamed lower-price Ozempic

  • CityNews
MAVIRET receives Health Canada Approval for the Treatment of Acute Hepatitis C Virus
  • Jan 07, 2026

MAVIRET receives Health Canada Approval for the Treatment of Acute Hepatitis C Virus

  • CISION
Novo Nordisk prepares new cheaper version of Ozempic as generics face delays
  •  —
  • Jan 06, 2026

Novo Nordisk prepares new cheaper version of Ozempic as generics face delays

  • The Globe and Mail
Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war
  • Jan 06, 2026

Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war

  • The Guardian
'Hot girls on SSRIs': Antidepressants are trending on TikTok. Not everyone is happy about that
  • Jan 02, 2026

'Hot girls on SSRIs': Antidepressants are trending on TikTok. Not everyone is happy about that

  • National Post
Generic Ozempic can be made in Canada as of next week, but don’t expect to get it soon
  • Jan 02, 2026

Generic Ozempic can be made in Canada as of next week, but don’t expect to get it soon

  • CTV News
What to watch for in weight loss drugs in 2026
  • Jan 01, 2026

What to watch for in weight loss drugs in 2026

  • NBC News
The Guardian view on mRNA vaccines: they are the future – with or without Donald Trump
  • Jan 01, 2026

The Guardian view on mRNA vaccines: they are the future – with or without Donald Trump

  • The Guardian
  •  — 
  • Editorial
Drugmakers raise US prices on 350 medicines despite pressure from Trump
  •  —
  • Dec 31, 2025

Drugmakers raise US prices on 350 medicines despite pressure from Trump

  • Reuters
Vaccine makers end the year in red
  • Dec 31, 2025

Vaccine makers end the year in red

  • Reuters
US FDA approves new motion sickness drug
  •  —
  • Dec 31, 2025

US FDA approves new motion sickness drug

  • Reuters
Alzheimer's Fully Reversed in Mice, Scientists Say
  • Dec 31, 2025

Alzheimer's Fully Reversed in Mice, Scientists Say

  • Futurism
Genmab scraps development of experimental cancer therapy
  • Dec 30, 2025

Genmab scraps development of experimental cancer therapy

  • Reuters
The Year Ahead: Health
  • Dec 30, 2025

The Year Ahead: Health

  • MacLean's
  •  — 
  • Editorial
What It's Like When Your Wife Goes on Testosterone
  • Dec 27, 2025

What It's Like When Your Wife Goes on Testosterone

  • The New York Times
Trump Announces Pricing Deals With Nine More Drugmakers
  •  —
  • Dec 27, 2025

Trump Announces Pricing Deals With Nine More Drugmakers

  • The New York Times
No fixes yet for B.C.'s expensive drugs for rare diseases program five months after premier called for change
  • Dec 27, 2025

No fixes yet for B.C.'s expensive drugs for rare diseases program five months after premier called for change

  • Vancouver Sun
Johnson & Johnson halts mid-stage trial of experimental eczema drug
  • Dec 27, 2025

Johnson & Johnson halts mid-stage trial of experimental eczema drug

  • Reuters
ADHD drugs may boost arousal more than attention
  • Dec 27, 2025

ADHD drugs may boost arousal more than attention
2025 was a year of breakthroughs in health and medicine. Here are five
  •  —
  • Dec 25, 2025

2025 was a year of breakthroughs in health and medicine. Here are five

  • The Globe and Mail
Health Canada approves first drug specifically made to treat moderate to severe postpartum depression
  • Dec 25, 2025

Health Canada approves first drug specifically made to treat moderate to severe postpartum depression

  • National Post
Consultation: Draft guidance on decentralized clinical trials
  • Dec 25, 2025

Consultation: Draft guidance on decentralized clinical trials

  • Government of Canada

Get Canada’s essential briefing on health policy, science, and system change.  Get Briefing